Yuanbao Insurance (Ticker: YB) reported second-quarter 2026 results on Tuesday that showed robust growth across key metrics, with total revenue rising 30.1% year-over-year to RMB 1.392 billion and net income surging 35.6% to RMB 413.2 million.
Non-GAAP adjusted net income came in at RMB 431.2 million, up 32.6% from a year earlier, with a non-GAAP adjusted net income margin of 31.0%. The company posted earnings per share of $1.41 for the quarter.
Revenue was split between insurance distribution services, which generated RMB 457.4 million—up 30.4%—and system services at RMB 881.9 million, up 22.8%. A newly launched advertising services segment contributed RMB 52.8 million in its first full quarter.
Operating profit reached RMB 413 million, matching the 35.6% growth rate of net income. However, operating costs and expenses rose 21.9% to RMB 341.3 million, including a sharp 139.1% increase in operations and support expenses to RMB 97.8 million.
Selling and marketing expenses totaled RMB 679.3 million, up 12.8%, while general administrative expenses climbed 36.3% to RMB 64.8 million. Research and development spending rose 21.7% to RMB 99.5 million. Income tax expense jumped to RMB 59.9 million from RMB 11.1 million a year ago.
The company reported a gross profit margin of 96.4% over the trailing twelve months. Cash and short-term investments stood at RMB 5.16 billion as of June 30, 2026, representing a 50.9% year-over-year increase and an 8.8% rise from the end of Q1. Operating cash flow for the quarter was RMB 419.1 million.
On the operational front, CEO Rui Fang highlighted that Yuanbao's AI model matrix now exceeds 5,100 models analyzing more than 5,900 features across the insurance journey. Claims processing accuracy for material classification reached 95%, with average key field extraction at approximately 94%. The intelligent claims assistance system cut settlement times for claims under RMB 10,000 by 41%.
Product upgrades included the Super Medical Insurance series, refreshed in June to add special needs public hospital resources and coverage for advanced drugs and medical devices, and the Complete Guardian line launched in May, which waives health disclosure requirements and covers general pre-existing conditions.
Investor Relations Associate Director Stella Liu noted the company published its 2025 China Internet Insurance Consumer Insights Report in partnership with Tsinghua University's PBC School of Finance.
In capital return activity, Yuanbao has repurchased approximately 114,000 ADSs for about $1.6 million under a $15 million share repurchase program as of August 31, 2026.
Shares rose 1.19% in premarket trading to $13.60 from a previous close of $13.44. The stock has traded between $12.01 and $25.98 over the past 52 weeks.
